Joon Lee
Stock Analyst at Truist Securities
(4.55)
# 254
Out of 4,712 analysts
111
Total ratings
51.52%
Success rate
30.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $550 → $460 | $409.58 | +12.31% | 2 | Dec 23, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $17 → $36 | $13.32 | +170.27% | 3 | Nov 12, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $30 → $36 | $21.51 | +67.36% | 7 | Nov 11, 2024 | |
| EDIT Editas Medicine | Maintains: Buy | $12 → $8 | $1.24 | +547.77% | 7 | Nov 5, 2024 | |
| ARGX argenx SE | Maintains: Buy | $540 → $660 | $634.53 | +4.01% | 11 | Oct 31, 2024 | |
| SAGE Sage Therapeutics | Maintains: Hold | $13 → $8 | $5.46 | +46.65% | 11 | Oct 30, 2024 | |
| CRMD CorMedix | Maintains: Buy | $12 → $17 | $8.38 | +102.86% | 7 | Oct 22, 2024 | |
| VRNA Verona Pharma | Maintains: Buy | $38 → $44 | $45.15 | -2.54% | 5 | Oct 9, 2024 | |
| CORT Corcept Therapeutics | Maintains: Buy | $65 → $76 | $51.67 | +47.09% | 7 | Sep 30, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $118 → $90 | $66.79 | +34.76% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.68 | +754.70% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $100 | $40.50 | +146.91% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $12.10 | +891.74% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $0.24 | +4,135.49% | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $42.21 | +184.29% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 | $77.12 | +94.51% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 | $86.10 | +74.21% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $18.46 | +252.21% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $123.63 | +61.77% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.82 | +175.48% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.76 | +212.68% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $3.25 | +8,515.38% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $14.42 | +135.78% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Dec 23, 2024
Maintains: Buy
Price Target: $550 → $460
Current: $409.58
Upside: +12.31%
Wave Life Sciences
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $13.32
Upside: +170.27%
Catalyst Pharmaceuticals
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $21.51
Upside: +67.36%
Editas Medicine
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.24
Upside: +547.77%
argenx SE
Oct 31, 2024
Maintains: Buy
Price Target: $540 → $660
Current: $634.53
Upside: +4.01%
Sage Therapeutics
Oct 30, 2024
Maintains: Hold
Price Target: $13 → $8
Current: $5.46
Upside: +46.65%
CorMedix
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $8.38
Upside: +102.86%
Verona Pharma
Oct 9, 2024
Maintains: Buy
Price Target: $38 → $44
Current: $45.15
Upside: -2.54%
Corcept Therapeutics
Sep 30, 2024
Maintains: Buy
Price Target: $65 → $76
Current: $51.67
Upside: +47.09%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $66.79
Upside: +34.76%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.68
Upside: +754.70%
Aug 12, 2024
Maintains: Buy
Price Target: $120 → $100
Current: $40.50
Upside: +146.91%
Jun 24, 2024
Maintains: Buy
Price Target: $120
Current: $12.10
Upside: +891.74%
Jun 18, 2024
Maintains: Buy
Price Target: $10
Current: $0.24
Upside: +4,135.49%
Jun 17, 2024
Maintains: Buy
Price Target: $120
Current: $42.21
Upside: +184.29%
May 16, 2024
Maintains: Buy
Price Target: $150
Current: $77.12
Upside: +94.51%
Mar 26, 2024
Maintains: Buy
Price Target: $150
Current: $86.10
Upside: +74.21%
Mar 25, 2024
Reiterates: Buy
Price Target: $65
Current: $18.46
Upside: +252.21%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $123.63
Upside: +61.77%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.82
Upside: +175.48%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $5.76
Upside: +212.68%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $3.25
Upside: +8,515.38%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $14.42
Upside: +135.78%